Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,440.65 +59.30 (+0.71%) Bitcoin USD
61,221.62 -806.74 (-1.30%) CMC Crypto 200
1,302.78 -55.23 (-4.18%)
Semler Scientific, Inc. (SMLR)
| Previous close | 22.96 |
| Open | 22.95 |
| Bid | 22.49 x 100 |
| Ask | 28.31 x 200 |
| Day's range | 21.82 - 22.99 |
| 52-week range | 20.88 - 53.38 |
| Volume | |
| Avg. volume | 87,519 |
| Market cap | 159.395M |
| Beta (5Y monthly) | 0.92 |
| PE ratio (TTM) | 8.62 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Semler Scientific® Reports First Quarter 2024 Financial Results
Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today reported financial results for the first quarter ended March 31, 2024.
- PR Newswire
Semler Scientific to Report First Quarter Financial Results and Host Conference Call on May 7, 2024
Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the first quarter ended March 31, 2024, after the close of U.S. financial markets on Tuesday, May 7, 2024. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Renae Cormier, c
- PR Newswire
Semler Scientific Reports Fourth Quarter and Full Year 2023 Financial Results
Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today reported financial results for the fourth quarter and full year ended December 31, 2023.
